TRAPPC12
protein-codingtrafficking protein particle complex subunit 12, the group of Trafficking protein particle complex subunits|Tetratricopeptide repeat domain containing
Gene summary
Involved in several processes, including endoplasmic reticulum to Golgi vesicle-mediated transport; positive regulation of protein localization to kinetochore; and regulation of kinetochore assembly. Located in several cellular components, including endoplasmic reticulum-Golgi intermediate compartment; kinetochore; and perinuclear region of cytoplasm. Part of TRAPP complex. [provided by Alliance of Genome Resources, Jul 2025]
- TTC15
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~105.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0044696
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0044696
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0044696
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0044696
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TRAPPC12 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_016030.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 56 | 8 | 67 | ||
| missense | 1 | 199 | 22 | 3 | 225 | |
| nonsense | 4 | 3 | 3 | 10 | ||
| start loss | 1 | 1 | ||||
| frameshift | 5 | 8 | 1 | 14 | ||
| splice donor/acceptor (+/-2bp) | 1 | 5 | 7 | 13 | ||
| Total | 10 | 17 | 214 | 78 | 11 | 330 |
Highest pathogenic variant AF is 0.000021344864
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_057114.5 | 11 | MANE Select | |
| Ensembl | ENSP00000324318.5 | 11 | MANE Select | |
| RefSeq | NP_001308031.1 | 11 | Standard | |
| Ensembl | ENSP00000371544.2 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Vesicle-mediated transport
- Membrane Trafficking
- Rab regulation of trafficking
- RAB GEFs exchange GTP for GDP on RABs
Biological Process
- proteolysis
- endoplasmic reticulum to Golgi vesicle-mediated transport
- Golgi organization
- protein complex oligomerization
- metaphase plate congression
Molecular Function
- endopeptidase activity
- protein binding
- Rab guanyl-nucleotide exchange factor activity
Cellular Component
- kinetochore
- nucleus
- endoplasmic reticulum-Golgi intermediate compartment
- cytosol
- TRAPP complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000324266
- Coding exons
- 11
- Length
- 105420
- Individuals with no LoFs
- 125685
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 63
- Defined
- 125748
- p
- 0.000251
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.160 | 457 | 467 | 0.979 | 0.0000318 | 4744 |
| Missense (PolyPhen) | 136 | 143.54 | 0.94748 | 1459 | ||
| Synonymous | 0.371 | 213 | 220 | 0.968 | 0.0000184 | 1466 |
| Loss of Function | 0.713 | 26 | 30.2 | 0.860 | 0.00000152 | 331 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00052 | 0.00046 | rare |
| Ashkenazi Jewish | 0.00051 | 0.00050 | rare |
| East Asian | 0.00017 | 0.00016 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00026 | 0.00024 | rare |
| South Asian | 0.00025 | 0.00023 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the TRAPP complex, which is involved in endoplasmic reticulum to Golgi apparatus trafficking at a very early stage (PubMed:21525244, PubMed:28777934). Also plays a role in chromosome congression, kinetochore assembly and stability and controls the recruitment of CENPE to the kinetochores (PubMed:25918224). {ECO:0000269|PubMed:21525244, ECO:0000269|PubMed:25918224, ECO:0000269|PubMed:28777934}.;
- Disease
- DISEASE: Encephalopathy, progressive, early-onset, with brain atrophy and spasticity (PEBAS) [MIM:617669]: An autosomal recessive, progressive encephalopathy characterized by central nervous system atrophy and dysfunction, spasticity, microcephaly, global developmental delay, and hearing loss. {ECO:0000269|PubMed:28777934}. Note=The disease is caused by mutations affecting the gene represented in this entry. Cells display a fragmented Golgi apparatus (PubMed:28777934). {ECO:0000269|PubMed:28777934}.;
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- RVIS EVS
- -0.39
- RVIS percentile EVS
- 27.05
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |